Impact of SARS-CoV-2 on the clinical presentation of juvenile idiopathic inflammatory myopathies
Abstract Background Growing evidence suggests that infection with severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) may trigger idiopathic inflammatory myopathies (IIM). Few studies have described individual juvenile IIM (JIIM) cases following SARS-CoV-2 infection, and none explored its p...
Main Authors: | Jessica Perfetto, Donna A. Yoo, Carolina Y. Tamashiro, Megan M. Perron, Natalia Vasquez-Canizares, Dawn M. Wahezi |
---|---|
Format: | Article |
Language: | English |
Published: |
BMC
2023-08-01
|
Series: | Pediatric Rheumatology Online Journal |
Subjects: | |
Online Access: | https://doi.org/10.1186/s12969-023-00861-4 |
Similar Items
-
Myositis autoantibodies in a racially diverse population of children with idiopathic inflammatory myopathies
by: Megan Mariko Perron, et al.
Published: (2021-06-01) -
Juvenile idiopathic inflammatory myopathies: A clinicopathological study with emphasis on muscle histology
by: Sundaram Challa, et al.
Published: (2019-01-01) -
Clinical and autoantibody phenotypes of juvenile dermatomyositis
by: Oksana Boyarchuk, et al.
Published: (2022-08-01) -
Morphological Characteristics of Idiopathic Inflammatory Myopathies in Juvenile Patients
by: Anne Schänzer, et al.
Published: (2021-12-01) -
Evaluation of disease course and major complications in juvenile idiopathic inflammatory myopathy patients
by: Melike Mehveş Kaplan, et al.
Published: (2024-11-01)